IRTC iRhythm Technologies, Inc. logo

IRTC iRhythm Technologies, Inc.

Healthcare
$116.56-1.11%ClosedMarket Cap: $3.83B

As of 2026-05-25

Valuation

View Details

P/E (TTM)

PEG

P/B

23.50

P/S

4.86

EV/EBITDA

899.73

DCF Value

$80.92

FCF Yield

0.5%

Div Yield

0.0%

Margins & Returns

Gross Margin

71.0%

Operating Margin

-2.7%

Net Margin

-3.5%

ROE

-20.6%

ROA

-2.8%

ROIC

-2.4%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$199.4M$-13.9M$
Q4 null$208.9M$5.6M$
FY null$747.1M$-44.6M$
Q3 null$192.9M$-5.2M$

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$193.67

Target (Median)

$184.00

Target Range

$160.00 - $255.00

2 Strong Buy12 Buy1 Hold0 Sell0 Strong Sell
B of A SecuritiesBuy
2026-05-18
CitigroupBuy
2026-05-04
JP MorganOverweight
2026-05-01
NeedhamBuy
2026-05-01
Canaccord GenuityBuy
2026-05-01

Trading Activity

Insider Trades

View All
TALWALKAR ABHIJIT Ydirector
SellTue May 12
TALWALKAR ABHIJIT Ydirector
SellTue May 12
TALWALKAR ABHIJIT Ydirector
SellTue May 12
TALWALKAR ABHIJIT Ydirector
SellTue May 12
TALWALKAR ABHIJIT Ydirector
SellTue May 12

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

US

Exchange

Beta

1.33

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

Peers